Drug Maker Structure Therapeutics Offers Big Bet on ‘Diabesity’ With IPO
One of the first major biotech deals of the new year is offering investors a big bet on diabetes and obesity treatments. Drug developer Structure Therapeutics has set terms for … Read More
